Effects of Walking Apnea At Low Lung Volume on Hypoalgesia
Launched by UNIVERSIDAD REY JUAN CARLOS · Oct 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special breathing exercise, called walking apneas at low lung volume, affects pain sensitivity in healthy adults. The researchers want to see if doing this exercise for six minutes can help reduce the feeling of pain, which is known as hypoalgesia. They will also check how this exercise impacts heart and lung function during the activity.
To participate, you need to be between 18 and 64 years old and healthy, meaning you shouldn't have any serious medical conditions like heart or lung diseases, a history of seizures, or be currently pregnant. You also shouldn't be taking any medication or experiencing pain on the day of the trial. If you join, you can expect to take part in this walking and breathing exercise and help researchers understand more about how our bodies respond to pain in different situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Asymptomatic subjects aged between 18 and 64 years.
- Exclusion Criteria:
- • Cardiovascular, respiratory, metabolic, neurological or osteomuscular signs or pathologies.
- • History of epilepsy.
- • Pregnant
- • Pharmacological treatment.
- • Participants who present any type of pain on the day of the measurements or who have frequently suffered pain during the previous 4 weeks.
About Universidad Rey Juan Carlos
Universidad Rey Juan Carlos (URJC) is a prominent academic institution located in Madrid, Spain, dedicated to advancing knowledge and research in various fields, including health sciences. With a commitment to innovation and excellence, URJC actively engages in clinical trials aimed at improving patient care and outcomes. The university's multidisciplinary approach fosters collaboration among researchers, clinicians, and industry partners, ensuring that its clinical research is grounded in scientific rigor and ethical standards. Through its robust infrastructure and expertise, Universidad Rey Juan Carlos is poised to contribute significantly to the advancement of medical research and the development of novel therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported